ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Jagsonpal Pharmaceuticals has designated Mr. Balmukund Keshav (DGM-IT) and Mr. Sanjay Singhal (GM-CQA & Regulatory Affairs) as Senior Management Personnel, effective July 29, 2026.
Jagsonpal Pharmaceuticals appointed Mr. Anil Kumar Matai as a Non-Executive Independent Director. His five-year term commenced on June 25, 2026.
Mrs. Pallavi Dinodia Gupta resigned as Independent Director from Jagsonpal Pharmaceuticals effective May 18, 2026. She cited personal reasons and professional commitments for stepping down.